With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
More is being learned about CDK12 and its role across a host of cancers. This retrospective look at over 25K patients undergoing tumor sequencing at MSKCC reports over 5% of prostate cancers harbor a CDK12 alteration portending more aggressive cancers and worse survival. | Nguyen, Eur Urol 2020